Exhibit 10.1


 


STOCK PURCHASE
AGREEMENT


 


THIS
STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of October 13th, 2022, by and among NextPlay Technologies,
Inc., a Nevada corporation (“Parent”) Next Fintech Holdings, Inc., a Delaware corporation and a subsidiary of Parent
(the “Company”), NextBank International, Inc., a Puerto Rico corporation licensed as an Act 273-2012 international
financial entity and a subsidiary of Parent (“NextBank”) and the investors listed on Exhibit A attached to this
Agreement (each a “Purchaser” and together the “Purchasers”).


 


WHEREAS,
the Purchasers, Company and NextBank have agreed that Purchasers shall invest an aggregate of US$15,000,000 in the Company in exchange
for (i) shares of common stock in the Company (the “Shares”), (ii) warrants to purchase shares of the Parent beneficially
owned by NextBank (the “Warrants”); and (iii), at the election of the Purchasers, the Purchasers’ right to exchange
the Shares for 18.8% of the equity in NextBank (the “NextBank Equity”, and together with the Shares and the Warrant,
the “Securities).


 


NOW,
THEREFORE, the parties hereby agree as follows:


 


1.   Purchase
and Sale of Securities.


 


1.1   Sale
and Issuance of Common Stock.


 


(a)   Subject
to the terms and conditions of this Agreement, each Purchaser agrees to purchase at the Closing and the Company agrees to sell and issue
to each Purchaser at the Closing that number of shares of Common Stock, $0.0001 par value per share (the “Common Stock”),
set forth opposite each Purchaser’s name on Exhibit A, at a purchase price of US$187,500.00 per share, for an aggregate of
80 Shares.


 


1.2   NextBank
Matters.


 


(a)   Sale
and Issuance of the Warrants. In connection with the purchase and sale of the Warrants, and subject to the terms and conditions of
this Agreement, each Purchaser agrees to purchase at the Closing and NextBank agrees to sell and issue to each Purchaser at the Closing,
Warrants to purchase that number of shares of Parent set forth opposite each Purchaser’s name on Exhibit A, which Warrants
have an exercise price of $0.50 per share and a term of three (3) years.


 


(b)   NextBank
Exchange Option. For a period commencing six (6) months following the Closing and ending on the date that is twenty-four (24) months
following the Closing, at the election of the Purchasers, the Purchasers may exchange all 80 of the Shares for equity of NextBank equal
to 18.8% of NextBank (the “NextBank Exchange Option”), subject to compliance with necessary regulatory approvals that
are required of NextBank prior to a change in ownership, if any.


 


(c)   Entity
Contribution. Within ninety (90) days of the Closing, Parent shall have contributed or caused to have been contributed all of the
issued and outstanding equity interests in NextBank to the Company such that NextBank will be a subsidiary of the Company.


 






    


     


    

 


1.3   Closing;
Delivery.


 


(a)   The
purchase and sale of the Securities shall take place remotely via the exchange of documents and signatures on October [•], 2022,
or at such time and place as the Company and the Purchasers mutually agree upon, orally or in writing (which time and place are designated
as the “Closing”). In the event there is more than one closing, the term “Closing” shall apply to
each such closing unless otherwise specified.


 


(b)   At
each Closing, the Company shall deliver to each Purchaser (i) a certificate representing the Shares being purchased by such Purchaser
at such Closing and (ii) the duly executed Warrant against payment of the purchase price therefor by wire transfer of immediately available
funds to a bank account designated by the Company.


 


1.4   Use
of Proceeds. In accordance with the directions of the Parent’s Board of Directors, the Company and/or Parent will use the proceeds
from the sale of the Securities for general corporate purposes.


 


1.5   Defined
Terms Used in this Agreement. In addition to the terms defined above, the following terms used in this Agreement shall be construed
to have the meanings set forth or referenced below.


 


(a)   “Affiliate”
means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common
control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person,
or any venture capital fund or registered investment company now or hereafter existing that is controlled by one (1) or more general partners,
managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.


 


(b)   “Code”
means the Internal Revenue Code of 1986, as amended.


 


(c)   “Company
Intellectual Property” means all patents, patent applications, registered and unregistered trademarks, trademark applications,
registered and unregistered service marks, service mark applications, tradenames, copyrights, trade secrets, domain names, information
and proprietary rights and processes, similar or other intellectual property rights, subject matter of any of the foregoing, tangible
embodiments of any of the foregoing, licenses in, to and under any of the foregoing, and in any and all such cases that are owned or used
by as are necessary to the Company in the conduct of the Company’s business as now conducted and as presently proposed to be conducted.


 


(d)   “Parent
SEC Documents” means all reports, schedules, forms, statements, registration statements, prospectuses and other documents required
to be filed with the SEC by Parent under the Securities Act or the Exchange Act (collectively, together with any exhibits and schedules
thereto and other information incorporated therein).


 






    2


     


    

 


(e)   “Investor
Rights Agreement” means the agreement among the Company and the Purchaser, dated as of the date of the Closing, in the form
of Exhibit D attached to this Agreement.


 


(f)   “Knowledge”
including the phrase “to the Company’s knowledge” shall mean the actual knowledge of the Company’s board
of directors.


 


(g)   “Material
Adverse Effect” means a material adverse effect on the business, assets (including intangible assets), liabilities, financial
condition, property, prospects or results of operations of the Company.


 


(h)   “Person”
means any individual, corporation, partnership, trust, limited liability company, association or other entity.


 


(i)   “Purchaser”
shall have the meaning set forth in the Preamble; provided, for purposes hereof, such term shall also include any successors or assigns
of such Purchasers.


 


(j)   “Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.


 


(k)   “Transaction
Agreements” means this Agreement and the Investor Rights Agreement.


 


2.   Representations
and Warranties of the Company. The Company hereby represents and warrants to each Purchaser that, except as disclosed in any publicly
available Parent SEC Document filed with the SEC on or after March 31, 2020 and at least two (2) business days prior to the date of this
Agreement (other than any disclosure contained in any part of any Parent SEC Document entitled “Risk Factors” or “Cautionary
Statement about Forward Looking Statements” or any other disclosures in any Parent SEC Document that are cautionary, predictive
or forward-looking in nature) which exceptions shall be deemed to be part of the representations and warranties made hereunder, the following
representations are true and complete as of the date of the Closing, except as otherwise indicated.


 


For
purposes of these representations and warranties (other than those in Sections 2.2, 2.3, 2.4, 2.5, and 2.6),
the term the “Company” shall include any subsidiaries of the Company, unless otherwise noted herein.


 


2.1   Organization,
Good Standing, Corporate Power and Qualification. The Company is a corporation duly organized, validly existing and in good standing
under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted
and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction
in which the failure to so qualify would have a Material Adverse Effect.


 






    3


     


    

 


2.2   Capitalization.


 


(a)   The
authorized capital of the Company consists, immediately prior to the Closing, of 800 shares of Common Stock, $0.0001 par value per share,
800 shares of which are issued and outstanding immediately prior to the Closing. All of the outstanding shares of Common Stock have been
duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws.
The Company holds no Common Stock in its treasury.


 


(b)   There
are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights)
or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or any securities convertible
into or exchangeable for shares of Common Stock.


 


(c)   None
of the Company’s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse
of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence
of any event or combination of events. The Company has never adjusted or amended the exercise price of any stock options previously awarded,
whether through amendment, cancellation, replacement grant, repricing, or any other means. The Company has no obligation (contingent or
otherwise) to purchase or redeem any of its capital stock.


 


(d)   The
Company has obtained valid waivers of any rights by other parties to purchase any of the Shares covered by this Agreement.


 


2.3   Authorization.
All corporate action required to be taken by the Company’s Board of Directors and stockholders in order to authorize the Company
to enter into the Transaction Agreements, and to issue the Shares at the Closing has been taken or will be taken prior to the Closing.
All action on the part of the officers of the Company necessary for the execution and delivery of the Transaction Agreements, the performance
of all obligations of the Company under the Transaction Agreements to be performed as of the Closing, and the issuance and delivery of
the Shares has been taken or will be taken prior to the Closing. The Transaction Agreements, when executed and delivered by the Company,
shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective
terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws
of general application relating to or affecting the enforcement of creditors’ rights generally and (ii) as limited by laws relating
to the availability of specific performance, injunctive relief, or other equitable remedies.


 


2.4   Valid
Issuance of Shares. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in
this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer
under the Transaction Agreements, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser.
Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement, the Shares will be issued in compliance
with all applicable federal and state securities laws.


 






    4


     


    

 


2.5   Governmental
Consents and Filings. Assuming the accuracy of the representations made by the Purchasers in Section 3 of this Agreement,
no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal,
state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated
by this Agreement, except for (i) any applicable regulatory approvals prior to the effectiveness of the NextBank Exchange Option, and
(ii) filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.


 


2.6   Litigation.
Except as set forth in the Parent SEC Documents, there is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation
pending or to the Company’s knowledge, currently threatened in writing (i) against the Company or any officer or director of the
Company arising out of their employment or board relationship with the Company; (ii) to the Company’s knowledge, that questions
the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated
by the Transaction Agreements; (iii) to the Company’s knowledge, that would reasonably be expected to have, either individually
or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company’s knowledge, any of its officers or directors
is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency
or instrumentality (in the case of officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation
by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings
or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any
of the Company’s employees, their services provided in connection with the Company’s business, any information or techniques
allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.


 


2.7   Compliance
with Other Instruments. The Company is not in violation or default (i) of any provisions of its Certificate of Incorporation, as amended,
or Bylaws, (ii) of any instrument, judgment, order, writ or decree, (iii) under any note, indenture or mortgage, or (iv) to its knowledge,
of any provision of federal or state statute, rule or regulation applicable to the Company, the violation of which would have a Material
Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated
by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage
of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement;
or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation,
forfeiture, or nonrenewal of any material permit or license applicable to the Company.


 


2.8   Agreements;
Actions.


 


(a)   The
Company has not (i) declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series
of its capital stock, or (ii) sold, exchanged or otherwise disposed of any of its assets or rights, other than in the ordinary course
of business. For the purposes of (a) and (b) of this Section 2.8, all indebtedness, liabilities, agreements, understandings,
instruments, contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated
with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such section.


 


(b)   The
Company is not a guarantor or indemnitor of any indebtedness of any other Person.


 






    5


     


    

 


2.9   Certain
Transactions.


 


(a)   Other
than (i) standard director and officer indemnification agreements approved by the Board of Directors, (iii) the purchase of shares of
the Company’s capital stock and the issuance of options to purchase shares of the Company’s Common Stock, in each instance,
approved in the written minutes of the Board of Directors (previously provided to the Purchasers or their respective counsel), and (iv)
the Transaction Agreements, there are no agreements, understandings or proposed transactions between the Company and any of its officers,
directors or consultants, or any Affiliate thereof.


 


(b)   The
Company is not indebted, directly or indirectly, to any of its directors, officers or employees or to their respective spouses or children
or to any Affiliate of any of the foregoing, other than in connection with expenses or advances of expenses incurred in the ordinary course
of business or employee relocation expenses and for other customary employee benefits made generally available to all employees.


 


2.10   Rights
of Registration and Voting Rights. The Company is not under any obligation to register under the Securities Act any of its currently
outstanding securities or any securities issuable upon exercise or conversion of its currently outstanding securities. To the Company’s
knowledge, no stockholder of the Company has entered into any agreements with respect to the voting of capital shares of the Company.


 


2.11   Property.
The property and assets that the Company owns are free and clear of all mortgages, deeds of trust, liens, loans and encumbrances, except
for statutory liens for the payment of current taxes that are not yet delinquent and encumbrances and liens that arise in the ordinary
course of business and do not materially impair the Company’s ownership or use of such property or assets. With respect to the property
and assets it leases, the Company is in compliance with such leases and holds a valid leasehold interest free of any liens, claims or
encumbrances other than those of the lessors of such property or assets. The Company does not own any real property.


 


2.12   Financials.
Except as consolidated into the Parent SEC Documents, the Company has no material liabilities or obligations, contingent or otherwise,
other than (i) liabilities incurred in the ordinary course of business subsequent to the date herewith; and (ii) obligations
under contracts and commitments incurred in the ordinary course of business, in all such cases, individually and in the aggregate would
not have a Material Adverse Effect. The Company maintains and will continue to maintain a standard system of accounting established and
administered in accordance with generally accepted accounting principles and “segment reporting.”


 






    6


     


    

 


2.13   Changes.
Since May 31, 2022 there has not been:


 


(a)   any
change in the assets, liabilities, financial condition or operating results of the Company, except changes in the ordinary course of business
that have not caused, in the aggregate, a Material Adverse Effect;


 


(b)   any
damage, destruction or loss, whether or not covered by insurance, that would have a Material Adverse Effect;


 


(c)   any
waiver or compromise by the Company of a valuable right or of a material debt owed to it;


 


(d)   any
satisfaction or discharge of any lien, claim, or encumbrance or payment of any obligation by the Company, except in the ordinary course
of business and the satisfaction or discharge of which would not have a Material Adverse Effect;


 


(e)   any
material change to a material contract or agreement by which the Company or any of its assets is bound or subject;


 


(f)   any
material change in any compensation arrangement or agreement with any employee, officer, director or stockholder;


 


(g)   any
resignation or termination of employment of any officer of the Company;


 


(h)   any
mortgage, pledge, transfer of a security interest in, or lien, created by the Company, with respect to any of its material properties
or assets, except liens for taxes not yet due or payable and liens that arise in the ordinary course of business and do not materially
impair the Company’s ownership or use of such property or assets;


 


(i)   any
loans or guarantees made by the Company to or for the benefit of its employees, officers or directors, or any members of their immediate
families, other than travel advances and other advances made in the ordinary course of its business;


 


(j)   any
declaration, setting aside or payment or other distribution in respect of any of the Company’s capital stock, or any direct or indirect
redemption, purchase, or other acquisition of any of such stock by the Company;


 


(k)   any
sale, assignment or transfer of any Company Intellectual Property that could reasonably be expected to result in a Material Adverse Effect;


 


(l)   receipt
of notice that there has been a loss of, or material order cancellation by, any major customer of the Company; or


 


(m)   to
the Company’s knowledge, any other event or condition of any character, other than events affecting the economy or the Company’s
industry generally, that could reasonably be expected to result in a Material Adverse Effect.


 






    7


     


    

 


(n)   any
arrangement or commitment by the Company to do any of the things described in this Section 2.13.


 


2.14   Employee
Matters.


 


(a)   To
the Company’s knowledge, none of its employees is obligated under any contract (including licenses, covenants or commitments of
any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would materially
interfere with such employee’s ability to promote the interest of the Company or that would conflict with the Company’s business.
Neither the execution or delivery of the Transaction Agreements, nor the carrying on of the Company’s business by the employees
of the Company, nor the conduct of the Company’s business as now conducted and as presently proposed to be conducted, will, to the
Company’s knowledge, conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under,
any contract, covenant or instrument under which any such employee is now obligated.


 


(b)   The
Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent
with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Company’s
Board of Directors.


 


2.15   Tax
Returns and Payments. There are no federal, state, county, local or foreign taxes due and payable by the Company which have not been
timely paid. There are no accrued and unpaid federal, state, country, local or foreign taxes of the Company which are due, whether or
not assessed or disputed. There have been no examinations or audits of any tax returns or reports by any applicable federal, state, local
or foreign governmental agency. The Company has duly and timely filed all federal, state, county, local and foreign tax returns required
to have been filed by it and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.


 


2.16   Insurance.
The Company has in full force and effect insurance policies concerning such casualties as would be reasonable and customary for companies
like the Company, with extended coverage, sufficient in amount (subject to reasonable deductions) to allow it to replace any of its properties
that might be damaged or destroyed.


 


2.17   Permits.
The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which
could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such
franchises, permits, licenses or other similar authority.


 


2.18   Corporate
Documents. The Certificate of Incorporation, as amended, and Bylaws of the Company as of the date of this Agreement are in the form
made available to the Purchasers. The copy of the minute books of the Company provided to the Purchasers contains minutes of all meetings
of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of
incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders.


 






    8


     


    

 


3.   Representations
and Warranties of the Purchasers. Each Purchaser hereby represents and warrants to the Company, severally and not jointly, that:


 


3.1   Authorization.
The Purchaser has full power and authority to enter into the Transaction Agreements. The Transaction Agreements to which the Purchaser
is a party, when executed and delivered by the Purchaser, will constitute valid and legally binding obligations of the Purchaser, enforceable
against such Purchaser in accordance with their terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors’ rights generally,
and as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies, or (b) to
the extent limited by applicable federal or state securities laws.


 


3.2   Purchase
Entirely for Own Account. This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to the Company,
which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Shares to be acquired by the Purchaser
will be acquired for investment for the Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or
distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise
distributing the same. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract,
undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person,
with respect to any of the Shares. The Purchaser has not been formed for the specific purpose of acquiring the Shares.


 


3.3   Disclosure
of Information. The Purchaser has had an opportunity to discuss the Company’s business, management, financial affairs and the
terms and conditions of the offering of the Shares with the Company’s management and has had an opportunity to review the Company’s
facilities. The foregoing, however, does not limit or modify the representations and warranties of the Company in Section 2
of this Agreement or the right of the Purchasers to rely thereon.


 


3.4   Risk
Factors. The Purchaser has had an opportunity to review investment risk factors, including those listed in the Parent SEC Documents.


 


3.5   Restricted
Securities. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason
of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature
of the investment intent and the accuracy of the Purchaser’s representations as expressed herein. The Purchaser understands that
the Shares are “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant to these
laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified
by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that
the Company has no obligation to register or qualify the Shares for resale. The Purchaser further acknowledges that if an exemption from
registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and
manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser’s
control, and which the Company is under no obligation and may not be able to satisfy.


 






    9


     


    

 


3.6   No
Public Market. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances
that a public market will ever exist for the Shares.


 


3.7   Legends.
The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one
or all of the following legends:


 


“THE SHARES
REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW
TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT
RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES
ACT OF 1933.”


 


(a)   Any
legend set forth in, or required by, the other Transaction Agreements.


 


(b)   Any
legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate,
instrument, or book entry so legended.


 


3.8   Accredited
Investor. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.


 


3.9   Bad
Actor. Neither the Purchaser, nor any of its shareholders, members, managers, general or limited partners, directors, affiliates or
executive officers, is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under
the Securities Act.


 


3.10   No
General Solicitation. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either
directly or indirectly, including, through a broker or finder (a) engaged in any general solicitation, or (b) published any
advertisement in connection with the offer and sale of the Shares.


 


3.11   Exculpation
Among Purchasers. The Purchaser acknowledges that it is not relying upon any Person, other than the Company and its officers and directors,
in making its investment or decision to invest in the Company. The Purchaser agrees that neither any Purchaser nor the respective controlling
Persons, officers, directors, partners, agents, or employees of any Purchaser shall be liable to any other Purchaser for any action heretofore
taken or omitted to be taken by any of them in connection with the purchase of the Shares.


 






    10


     


    

 


3.12   Residence.
If the Purchaser is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set
forth on Exhibit A; if the Purchaser is a partnership, corporation, limited liability company or other entity, then the office
or offices of the Purchaser in which its principal place of business is identified in the address or addresses of the Purchaser set forth
on Exhibit A.


 


4.   Conditions
to the Purchasers’ Obligations at the Closing. The obligations of each Purchaser
to purchase the Securities at the Closing are subject to the fulfillment, on or before such Closing, of each of the following conditions,
unless otherwise waived:


 


4.1   Representations
and Warranties. The representations and warranties of the Company contained in Section 2 shall be true and correct in
all respects as of such Closing.


 


4.2   Performance.
The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that
are required to be performed or complied with by the Company on or before such Closing.


 


4.3   Qualifications.
All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state
that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective
as of such Closing.


 


4.4   Investor
Rights Agreement. The Company and each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser’s
performance hereunder), shall have executed and delivered the Investor Rights Agreement.


 


4.5   Warrant.
NextBank shall have executed and delivered the Warrant.


 


4.6   Proceedings
and Documents. All corporate and other proceedings in connection with the transactions contemplated at the Closing and all documents
incident thereto shall be reasonably satisfactory in form and substance to each Purchaser, and each Purchaser (or its respective counsel)
shall have received all such counterpart original and certified or other copies of such documents as reasonably requested. Such documents
may include good standing certificates.


 


5.   Conditions
of the Company Obligations at Closing. The obligations of the Company to sell the Securities to the Purchasers at the Closing are
subject to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived:


 


5.1   Representations
and Warranties. The representations and warranties of each Purchaser contained in Section 3 shall be true and correct in all
respects as of such Closing.


 






    11


     


    

 


5.2   Performance.
The Purchasers shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement
that are required to be performed or complied with by them on or before such Closing.


 


5.3   Qualifications.
All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state
that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective
as of the Closing.


 


5.4   Investor
Rights Agreement. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered
the Investor Rights Agreement.


 


6.   Miscellaneous.


 


6.1   Survival
of Warranties. Unless otherwise set forth in this Agreement, the representations and warranties of the Company and the Purchasers
contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement until the date that is thirty
(30) days following the Closing.


 


6.2   Successors
and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors
and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement,
except as expressly provided in this Agreement.


 


6.3   Governing
Law. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of law principles that
would result in the application of any law other than the law of the State of Delaware.


 


6.4   Counterparts.
This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying
with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered
shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.


 


6.5   Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing
or interpreting this Agreement.


 


6.6   Notices.


 


(a)   General.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given
upon the earlier of actual receipt, or (a) personal delivery to the party to be notified, (b) when sent, if sent by electronic mail during
normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next business day,
(c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) business
day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written
verification of receipt. All communications shall be sent to the respective parties at their address as set forth on the signature page
or Exhibit A, or to such e-mail address or address as subsequently modified by written notice given in accordance with this Section 6.6.
If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to Procopio, Cory, Hargreaves &
Savitch LLP, 12544 High Bluff Drive, Suite 400, San Diego, California, Attention: Christopher L. Tinen, Esq., at christopher.tinen@procopio.com.


 






    12


     


    

 


(b)   Consent
to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the Delaware General Corporation
Law (the “DGCL”), as amended or superseded from time to time, by electronic transmission pursuant to Section 232 of
the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser’s name on the signature page or Exhibit
A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic transmission
is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail
address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each Purchaser
agrees to promptly notify the Company of any change in its e-mail address, and that failure to do so shall not affect the foregoing.


 


6.7   Indemnification.
Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature
of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability
or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees
to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder’s
or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability)
for which the Company or any of its officers, employees or representatives is responsible.


 


6.8   Attorneys’
Fees. If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction
Agreements, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition
to any other relief to which such party may be entitled.


 


6.9   Amendments
and Waivers. Any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and (i)
the holders of at least a majority of the then-outstanding Shares, or (ii) for an amendment, termination or waiver effected prior to the
Closing, Purchasers obligated to purchase a majority of the Shares to be issued at the Closing. Any amendment or waiver effected in accordance
with this Section 6.9 shall be binding upon the Purchasers and each transferee of the Shares, each future holder of all such
securities, and the Company.


 


6.10   Severability.
The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.


 






    13


     


    

 


6.11   Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach
or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting
party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach
or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default
theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any
breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must
be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement
or by law or otherwise afforded to any party, shall be cumulative and not alternative.


 


6.12   Entire
Agreement. This Agreement (including the Exhibits hereto) and the other Transaction Agreements constitute the full and entire understanding
and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject
matter hereof existing between the parties are expressly canceled.


 


6.13   Dispute
Resolution. Any unresolved controversy or claim arising out of or relating to this Agreement, except as otherwise provided in
this Agreement, shall be submitted to arbitration by one (1) arbitrator mutually agreed upon by the parties, and if no agreement can be
reached within thirty (30) days after names of potential arbitrators have been proposed by the American Arbitration Association (the “AAA”),
then by one (1) arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement and
who is chosen by the AAA. The arbitration shall take place in New Castle County, Delaware, in accordance with the AAA rules then in effect,
and judgment upon any award rendered in such arbitration will be binding and may be entered in any court having jurisdiction thereof.
There shall be limited discovery prior to the arbitration hearing as follows: (a) exchange of witness lists and copies of documentary
evidence and documents relating to or arising out of the issues to be arbitrated, (b) depositions of all party witnesses and (c)
such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance
with the Delaware Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award
or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of
such proceedings.


 


The
prevailing party shall be entitled to reasonable attorney’s fees, costs, and necessary disbursements in addition to any other relief
to which such party may be entitled.


 


Waiver
of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF
THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS
INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION,
INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND
STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY
EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL,
AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.


 


6.14   Waiver
of Conflicts. Each party to this Agreement acknowledges that Procopio, Cory, Hargreaves & Savitch LLP(“Procopio”),
counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the
Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the
representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges
that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) Procopio represents only the Company
with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to Procopio’s representation
of the Purchasers in matters not substantially related to this Agreement, and the Purchasers give their informed consent to Procopio’s
representation of the Company in connection with this Agreement and the transactions contemplated hereby.


 


[Signature Page Follows]


 




    14


     


    

 


IN
WITNESS WHEREOF, the parties have executed this Stock Purchase Agreement as of the date first written above.


 


	 	COMPANY: Next Fintech Holdings Inc.
	 	 	 
	 	By:	/s/ J. Todd Bonner
	 	Name:	J. Todd Bonner 
	 		(print)
	 	Title:	Director



 


Signature
Page to Stock Purchase Agreement


 




     


     


    

 


IN
WITNESS WHEREOF, the undersigned has executed this Stock Purchase Agreement as of the date first written above, solely for purposes of
its obligations under Section 1.2(c).


 


	 	PARENT: NextPlay Technologies Inc.
	 	 	 
	 	By:	/s/ J. Todd Bonner
	 	Name:	J. Todd Bonner
	 		(print)
	 	Title:	Chairman



 


Signature Page to Stock Purchase
Agreement


 




     


     


    

 


 


IN
WITNESS WHEREOF, the undersigned has executed this Stock Purchase Agreement as of the date first written above, solely for purposes of
its obligations under Section 1.2.


 


	 	NEXTBANK:                   
	 	 	 
	 	By:	/s/ J. Todd Bonner
	 	Name:	J. Todd Bonner
	 		(print)
	 	Title:	Director



 


Signature Page to Stock Purchase
Agreement


 




     


     


    

 


IN
WITNESS WHEREOF, the parties have executed this Stock Purchase Agreement as of the date first written above.


 


	 	PURCHASERS:
	 	 	
	 	
	 	(Print Name of Purchaser)
	 	 	 
	 	Address: 	                         
	 	 	 
	 	By: 	/s/
	 	Name:	                       
	 	(print)
	 	Title:	 



 


Signature Page to Stock Purchase
Agreement


 




     


     


    

 


EXHIBITS


 


Exhibit
A - SCHEDULE OF PURCHASERS


 


Exhibit
B - FORM OF WARRANT


 


Exhibit
C - FORM OF Investor rights AGREEMENT


 




     


     


    

 


Exhibit A


 


SCHEDULE OF PURCHASERS


 


	 
Name and Address
	 	Number of

 Shares of

 NextFinTech

 Common Stock	 	 	Number of

 Warrants

 in NextPlay

 (NXTP) parent	 	 	Purchase Price	 
	 	 	 	80	 	 	 	1,000,000	 	 	 	US$15,000,000.00	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	TOTAL	 	 	80	 	 	 	1,000,000	 	 	 	US$15,000,000.00	 




 



     


     


    

 


EXHIBIT B


 


FORM OF WARRANT




 






     


     


    

 


Exhibit c


 


FORM
OF INVESTOR RIGHTS AGREEMENT